0 Évaluations

ID

15393

Description

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02150317

Lien

https://clinicaltrials.gov/show/NCT02150317

Mots-clés

  1. 29/05/2016 29/05/2016 -
Téléchargé le

29 mai 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Advanced Hepatocellular Carcinoma NCT02150317

    Eligibility Advanced Hepatocellular Carcinoma NCT02150317

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    male or female patients > 18 years and <=70 years of age.
    Description

    age

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    at least 2 radiologic imaging showing characteristic features of hepatocellular carcinoma or cytologic/histologic evidence.
    Description

    hepatocellular carcinoma

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C2239176
    tumor in liver and radiologically definable vascular invasion or extrahepatic metastasis.
    Description

    vascular invasion or extrahepatic metastasis

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0521157
    UMLS CUI [2]
    C0474915
    criteria of liver function: child a-b level, serum bilirubin ≤ 1.5 times the upper limit of normal value,alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value.
    Description

    child a-b level, serum bilirubin

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C4050412
    UMLS CUI [2]
    C0428441
    no dysfunction in major organs; blood routine, kidney function, cardiac function and lung function are basically normal.
    Description

    major organs

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0026766
    hb ≥90g/l,white blood cell count ≥3.000 cells/mm³,platelets ≥80.000 cells/mm³
    Description

    white blood cell count

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0023508
    patients who can understand this trial and have signed informed consent
    Description

    informed consent

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    patients with apparent cardiac, pulmonary, cerebral and renal dysfunction, which may affect the treatment of liver cancer.
    Description

    Study Subject Participation Status

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0525058
    UMLS CUI [2]
    C0009488
    patients with a medical history of other malignant tumors
    Description

    Malignant Neoplasms

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0006826
    subjects participating in other clinical trials
    Description

    subjects participating in other clinical trials

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C2348568
    liver function:child c
    Description

    Child-Pugh Class C

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C3831115
    no pathological evidence of hepatocellular carcinoma.
    Description

    no pathological evidence of hepatocellular carcinoma.

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0205469

    Similar models

    Eligibility Advanced Hepatocellular Carcinoma NCT02150317

    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    age
    Item
    male or female patients > 18 years and <=70 years of age.
    boolean
    C0001779 (UMLS CUI [1])
    hepatocellular carcinoma
    Item
    at least 2 radiologic imaging showing characteristic features of hepatocellular carcinoma or cytologic/histologic evidence.
    boolean
    C2239176 (UMLS CUI [1])
    vascular invasion or extrahepatic metastasis
    Item
    tumor in liver and radiologically definable vascular invasion or extrahepatic metastasis.
    boolean
    C0521157 (UMLS CUI [1])
    C0474915 (UMLS CUI [2])
    child a-b level, serum bilirubin
    Item
    criteria of liver function: child a-b level, serum bilirubin ≤ 1.5 times the upper limit of normal value,alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value.
    boolean
    C4050412 (UMLS CUI [1])
    C0428441 (UMLS CUI [2])
    major organs
    Item
    no dysfunction in major organs; blood routine, kidney function, cardiac function and lung function are basically normal.
    boolean
    C0026766 (UMLS CUI [1])
    white blood cell count
    Item
    hb ≥90g/l,white blood cell count ≥3.000 cells/mm³,platelets ≥80.000 cells/mm³
    boolean
    C0023508 (UMLS CUI [1])
    informed consent
    Item
    patients who can understand this trial and have signed informed consent
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Study Subject Participation Status
    Item
    patients with apparent cardiac, pulmonary, cerebral and renal dysfunction, which may affect the treatment of liver cancer.
    boolean
    C0525058 (UMLS CUI [1])
    C0009488 (UMLS CUI [2])
    Malignant Neoplasms
    Item
    patients with a medical history of other malignant tumors
    boolean
    C0006826 (UMLS CUI [1])
    subjects participating in other clinical trials
    Item
    subjects participating in other clinical trials
    boolean
    C2348568 (UMLS CUI [1])
    Child-Pugh Class C
    Item
    liver function:child c
    boolean
    C3831115 (UMLS CUI [1])
    no pathological evidence of hepatocellular carcinoma.
    Item
    no pathological evidence of hepatocellular carcinoma.
    boolean
    C0205469 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial